LPCN-1012
N/A
Report date: 2023/01/15 23:06:54
NME
Base Information
Drug NameLPCN-1012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A